Biora Therapeutics Achieves ISO 13485 Certification, Demonstrating The Co's Commitment To Compliance With The Most Rigorous Global Regulatory And Quality Standards
Biora Therapeutics Achieves ISO 13485 Certification, Demonstrating The Co's Commitment To Compliance With The Most Rigorous Global Regulatory And Quality Standards
Biora Therapeutics獲得ISO 13485認證，展示了公司對全球最嚴格的監管和質量標準的合規承諾
Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company reimagining therapeutic delivery, today announced it has been awarded ISO 13485:2016 certification by TÜV SÜD America, demonstrating the company's commitment to compliance with the most rigorous global regulatory and quality standards.
重新構想治療交付的生物技術公司Biora Therapeutics, Inc.（納斯達克股票代碼：BIOR）今天宣佈，它已獲得TUV SUD America頒發的ISO 13485:2016 認證，這表明該公司致力於遵守最嚴格的全球監管和質量標準。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。